by Joel Rothman | Nov 5, 2006 | NutriSupLaw
The FDA has scheduled a public hearing on the regulation of foods being marketed as “functional foods.” According to this Federal Register Notice, the purpose of the hearing is “for the agency to share its current regulatory framework and rationale...
by Joel Rothman | Oct 23, 2006 | NutriSupLaw
In a joint press release, the Federal Trade Commission and the Food and Drug Administration announced a “joint diabetes initiative” to stop deceptive internet advertisements and sales of products the agencies claim are misrepresented as cures or treatments for...
by Joel Rothman | Oct 5, 2006 | NutriSupLaw
Popular mangosteen functional beverage marketer XanGo has come under scrutiny from the FDA for its claims. To read the FDA warning letter to XanGo, click here. The FDA’s complaints about XanGo concern brochures for the product, some of which were designed to be...
by Joel Rothman | Sep 26, 2006 | NutriSupLaw
The DEA has arrested several executives associated with nutraceutical maker Hi-Tech Pharmaceuticals for a variety of offences relating to the distribution of adulterated generic drugs. To read the Department of Justice press release, click here. We previously...
by Joel Rothman | Sep 26, 2006 | NutriSupLaw
Steve Warshak, former CEO of embattled Berkley Nutraceuticals was finally indicted last week. The indictment is so large it had to be split up into separate PDF files in order to fit on the court e-filing system. The indictment brings criminal mail, wire and bank...
